Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). This is a 12 month study to
determine if Norditropin is safe and effective in children with IGF deficiency.